As a global leader in peripheral intervention, Abbott offers a broad portfolio of innovative and minimally invasive products including guide wires, balloon dilatation catheters and stent systems for the treatment of peripheral artery disease (PAD) and other venous diseases.
Peripheral vascular disease - caused by atherosclerosis, typically in the lower extremities - can result in claudication, which is a cramping pain in the leg when walking. More severe cases can result in pain at rest and, as ischemia worsens, ulceration. Blockages in renal arteries, iliac, femoral, and popliteal arteries may have debilitating effects on patients.
Placement of a metal stent in a stenotic or occluded blood vessel is intended to maintain patency and reestablish blood flow through the vessel by providing internal structural support. Given the broad range of challenges and the locations and types of blockages encountered, there is demand for a broad range of stent types and sizes paired with delivery and placement tools that may help to improve outcomes for our patients.
Peripheral Artery Disease (PAD) is a serious disease that afflicts 8.5 to 12 million adults 40 years and older in the United States. 1,2 Abbott is committed to fighting PAD and raising awareness - especially among underserved populations.